Jeffrey A. Golden, MD

Nina Ireland Distinguished Professor of Clinical Medicine and Surgery
University of California San Francisco
San Francisco, California

Jeffrey A. Golden, MD, is Nina Ireland Distinguished Professor of Clinical Medicine and Surgery at the University of California at San Francisco. He received his BA degree from Yale University in New Haven, Connecticut, and his medical degree from Washington University in St. Louis, Missouri. Dr. Golden completed his internship at San Francisco General Hospital. He completed his residency in internal medicine and his research fellowship at the Cardiovascular Research Institute of the University of California, San Francisco, where he studied ozone inhalation in humans as a model of asthma. Dr. Golden has been on the faculty in UCSF’s Department of Medicine since 1977 and is currently Director of the Bronchoscopy Service, Medical Director of Lung Transplantation, and co-Director of the Interstitial Lung Clinic.

Dr. Golden is involved primarily with clinical practice and clinical research in three main areas of interest: bronchoscopy, interstitial lung disease, and lung transplantation. He has been responsible for specific drug trials for idiopathic pulmonary fibrosis (IPF) that include a completed initial study of gamma interferon and ongoing studies with bosantan, gamma interferon, and inhaled iloprost.

The interstitial lung disease (ILD) clinic, which Dr. Golden has developed for over 25 years, includes 6 faculty members. The UCSF ILD program was awarded a Center of Excellence Grant from the Department of Medicine on which Dr. Golden is a co-investigator. In 2005, the program was selected to be one of 11 centers in the US to receive NIH sponsorship for clinical research. Dr. Golden also initiated the UCSF lung transplant program in 1991. Since 2002 it has become one of the top 10% in the world in terms of yearly procedures.

Dr. Golden has been published in numerous scientific journals, including the American Review of Respiratory Disease, Chest, the Journal of Nuclear Medicine, the Western Journal of Medicine, and the New England Journal of Medicine.

Disclosure Statement

The France Foundation relies upon faculty members to provide educational information in a manner that is objective and free from bias. In compliance with the Accreditation Council for Continuing Medical Education's (ACCME) Standards for Commercial Support, all faculty members are required to disclose any conflicts of interest related to the context of their participation in a CME activity. Faculty members have disclosed the following relationships with commercial interests:

Jeffrey A. Golden, MD, has received research support from Actelion, InterMune, and Roche and has served as a consultant for InterMune.